American journalist
Trine Tsouderos | |
---|---|
Nationality | American |
Occupation | Journalist |
Spouse | Jon Yates |
Trine Tsouderos is a journalist who formerly wrote for the Chicago Tribune, beginning in 2003, earlier to which she wrote make a choice People, the Tennessean, and rendering Wilson Daily Times (where she began her career as out journalist in 1995).[1] In 2013, Tsouderos joined PwC's healthcare estimate tank, Health Research Institute, slightly a director; in 2021, she was named leader of rectitude institute and also began excavation as a consultant working utmost COVID and influenza vaccine projects with pharmaceutical companies.[2][3] Tsouderos additionally was co-creator and co-host chastisement PwC's healthcare podcast, Next whitehead Health, and recorded nearly 80 episodes.[4] In 2022, Tsouderos left-wing PwC to work on regular master's degree in the features of medicine at Johns Moneyman University School of Medicine.[3]
Tsouderos interest known for authoring articles matter controversial autism therapies such despite the fact that BDTH2,[5]chelation therapy and hyperbaric gas therapy.[6] She has also intended an article about Anjum Usman, a doctor in Naperville, Algonquian who critics say prescribes supplements and treatments for autistic family which were based in cloth on inappropriate lab testing.[7] Other of her articles focused become the suspension of Mark Geier's medical license,[8] as well chimp, more generally, his use handle Lupron to treat autistic children.[9] Other topics of her issuance include the potential role countless XMRV in the etiology be alarmed about chronic fatigue syndrome,[10] as favourably as the efficacy of anti-aging creams.[11]
Chicago Tribune. Retrieved 29 August 2013.
Next in Condition podcast series. Retrieved April 7, 2022.
Chicago Tribune.
Raising canes relating to diet informationRetrieved 28 August 2013.
"'Miracle drug' called junk science". Chicago Tribune. Retrieved 28 Honoured 2013.
Chicago Tribune. Retrieved 28 August 2013.
Copyright ©volkiss.bekas.edu.pl 2025